BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 23901756)

  • 1. Insertion of reticuloendotheliosis virus long terminal repeat into the genome of CVI988 strain of Marek's disease virus results in enhanced growth and protection.
    Lupiani B; Lee LF; Kreager KS; Witter RL; Reddy SM
    Avian Dis; 2013 Jun; 57(2 Suppl):427-31. PubMed ID: 23901756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
    Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
    Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
    Witter RL; Kreager KS
    Avian Dis; 2004 Dec; 48(4):768-82. PubMed ID: 15666858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertion of reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of a very virulent Marek's disease virus alters its pathogenicity.
    Mays JK; Silva RF; Kim T; Fadly A
    Avian Pathol; 2012; 41(3):259-65. PubMed ID: 22702453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant field strain of Marek's disease (MD) virus with reticuloendotheliosis virus long terminal repeat insert lacking the meq gene as a vaccine against MD.
    Su S; Cui N; Zhou Y; Chen Z; Li Y; Ding J; Wang Y; Duan L; Cui Z
    Vaccine; 2015 Jan; 33(5):596-603. PubMed ID: 25562789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolation and characterization of a non-pathogenic Marek's disease virus with a naturally inserted REV LTR sequence].
    Chen R; Luo Q; Guo' K; Liu Z; Li H; Wang J
    Wei Sheng Wu Xue Bao; 2014 Jun; 54(6):670-8. PubMed ID: 25272816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing protocols for monitoring
    Faiz NM; Cortes AL; Phang YF; Gimeno IM
    Avian Pathol; 2024 Aug; 53(4):303-311. PubMed ID: 38411905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
    Lee LF; Kreager K; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
    Avian Dis; 2013 Jun; 57(2 Suppl):491-7. PubMed ID: 23901766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral insertional mutagenesis of a herpesvirus: a Marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication.
    Witter RL; Li D; Jones D; Lee LF; Kung HJ
    Avian Dis; 1997; 41(2):407-21. PubMed ID: 9201407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek's disease viruses.
    Gimeno IM; Dunn JR; Cortes AL; El-Gohary Ael-G; Silva RF
    Avian Dis; 2014 Jun; 58(2):232-43. PubMed ID: 25055627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model.
    Baigent SJ; Smith LP; Currie RJ; Nair VK
    Avian Pathol; 2007 Dec; 36(6):467-74. PubMed ID: 17994325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
    Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
    Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
    Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
    Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence analysis of the whole genome of a recombinant Marek's disease virus strain, GX0101, with a reticuloendotheliosis virus LTR insert.
    Su S; Cui N; Sun A; Li Y; Ding J; Chen Z; Zhao P; Cui Z
    Arch Virol; 2013 Sep; 158(9):2007-14. PubMed ID: 23553452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains.
    Zhang Y; Liu C; Yan F; Liu A; Cheng Y; Li Z; Sun G; Lv H; Wang X
    Vaccine; 2017 Aug; 35(36):4695-4701. PubMed ID: 28754487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificially inserting a reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of Marek's disease virus (MDV) alters expression of nearby MDV genes.
    Kim T; Mays J; Fadly A; Silva RF
    Virus Genes; 2011 Jun; 42(3):369-76. PubMed ID: 21340512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
    Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
    Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-Infection with Marek's Disease Virus and Reticuloendotheliosis Virus Increases Illness Severity and Reduces Marek's Disease Vaccine Efficacy.
    Sun GR; Zhang YP; Zhou LY; Lv HC; Zhang F; Li K; Gao YL; Qi XL; Cui HY; Wang YQ; Gao L; Pan Q; Wang XM; Liu CJ
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28635675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of a recombinant Marek's disease virus lacking the meq oncogene and evaluation on its immune efficacy against Marek's disease virus.
    Sun P; Cui N; Liu L; Su S; Cheng Z; Chen R; Li Y; Cui Z
    Poult Sci; 2020 Apr; 99(4):1939-1945. PubMed ID: 32241474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.